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Introduction: Elevated intra-abdominal pressure (IAP) has been identified as a cascade of pathophysiologic
changes leading in end-organ failure due to decreasing compliance of the abdomen and the development of
abdomen compartment syndrome (ACS). Spontaneous retroperitoneal hematoma (SRH) is a rare clinical entity seen
almost exclusively in association with anticoagulation states, coagulopathies and hemodialysis; that may cause ACS
among patients in the intensive care unit (ICU) and if treated inappropriately represents a high mortality rate.
Case Presentation: We report four patients (a 36-year-old Caucasian female, a 59-year-old White-Asian male, a
64-year-old Caucasian female and a 61-year-old Caucasian female) that developed an intra-abdominal hypertension
due to heparin-induced retroperitoneal hematomas after implantation of ventricular assist devices because of heart
failure. Three of the patients presented with dyspnea at rest, fatigue, pleura effusions in chest XR and increased
heart rate although b-blocker therapy. A 36-year old female (the forth patient) presented with sudden, severe
shortness of breath at rest, 10 days after an “acute bronchitis”. At the time of the event in all cases international
normalized ratio (INR) was <3.5 and partial thromboplastin time <65 sec. The patients were treated surgically, the
large hematomas were evacuated and the systemic manifestations of the syndrome were reversed.
Conclusion: Identifying patients in the ICU at risk for developing ACS with constant surveillance can lead to
prevention. ACS is the natural progression of pressure-induced end-organ changes and develops if IAP is not
recognized and treated in a timely manner. Failure to recognize and appropriately treat ACS is fatal while timely
intervention - if indicated - is associated with improvements in organ function and patient survival. Means for
surgical decision making are based on clinical indicators of adverse physiology, rather than on a single measured
parameter.
Background
Ventricular assist devices (VADs) have been demon-
strated to be effective in either bridging patients with
end-stage heart failure to transplantation or as long-
term support - destination therapy - or as a bridge to
myocardial recovery resulting in substantial improve-
ment in survival rates [1,2]. For every 1000 patients with
end-stage heart failure, the implantation of a left
ventricular assist device could prevent at least 270
deaths annually. The treatment effect is nearly four
times that of beta-blockers or angiotensin-converting -
enzyme inhibitors (ACE inhibitors), which have been
estimated to prevent 70 deaths for every 1000 patients
treated who receive either type of agent [3,4]. The
Achilles’ heel of Prolonged Ventricular Assist Device
Support has been right ventricular dysfunction and
device-related complications, such as thromboembolism,
infection, and bleeding. The latter is triggered by
changes in the coagulation system [5,6] and remains the
most common postoperative complication after VAD
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cases irrespective of device used or indication for
insertion.
Spontaneous retroperitoneal hematoma (SRH) on
the other hand is a distinctive clinical entity, most
commonly seen in association with patients with antic-
oagulation therapy, bleeding abnormalities, and haemo-
dialysis [7,8] and may represent one of the most serious
and potentially lethal complications of anticoagulation
therapy [9]. The large study of Sasson et al. [10] showed
that patients receiving heparin as anticoagulation ther-
apy should be carefully monitored for the development
of groin pain or leg weakness because of a SRH. Monica
M o u r t h ee ta lr e p o r t e dt h eonly case where abdominal
compartment syndrome was related to this clinical
entity [11].
The World Society of Abdominal Compartment Syn-
drome has defined Intra-abdominal hypertension as a
sustained or repeated pathologic elevation of IAP ≥ 12
mmHg whereas the same society defined the Abdominal
Compartment Syndrome as a sustained IAP > 20 mmHg
associated with new organ dysfunction or failure, with
signs of end-organ compromise, confirmed by alleviation
of symptoms on abdominal decompression. Both of these
entities compress the pulmonary parenchyma which




st case we report is of a 36-year-old Caucasian female
with severe heart failure secondary to virus induced myo-
carditis that required biventricular support with Thoratec
PVAD
(r) ventricular assist device (Thoratec Laboratories
Corp, Pleasanton, CA). She was initially treated with Furo-
semid (Lasix
(r))5 0 0m g / 5 0m lN a C lw i t har a t eo f5 - 1 0
mg/h, ACE inhibitors, and dobutamin
(r) 250 mg/50 ml
with a rate of 10 μg/KG BW/min. Despite maximal medi-
cal treatment, including levosimendan (Simdax
(r)) 25 mg/
500 ml G5% with a rate of 0.1 μg/KG BW/min, her clinical
and hemodynamic status deteriorated 36 hours later with
hypotension, cardiac index (CI) of 1.60 L/min/m
2 and
Figure 1 1
st case. CT - axial plan demonstrating a retroperitoneal hematoma adherent to the right psoas muscle, shifting the right renal lateral.
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The patient was evaluated and accepted for ventricular
assist device implantation.
Postoperatively, after spending 128 hours in the ICU
and while in mechanical ventilation, her liver and kidney
function promptly recovered, the inotropic agents were
reduced, and the patient remained clinically stable
under dobutamin & dopamine and heparin IV. Heparin
therapy was monitored three times per day, using the
partial thromboplastin time (aPTT) and the dose was
adjusted to attain the target 50 - 60 sec.
On the 7
th ICU-day the patient developed a tense, dis-
tended abdomen and became oliguric. Pulmonary vascu-
lar resistance was 305 dyn × sec/cm
5.A b d o m i n a l
ultrasound revealed an empty bladder with a urinary
catheter in situ and kidneys of normal size. Despite to an
adequate mean arterial pressure (65 mm Hg) and passage
of a nasogastric tube to decompress the stomach, oliguria
persisted. Intraabdominal pressure (IAP) was measured
via a urinary catheter and was shown to be 27 mm Hg,
which confirmed abdominal compartment syndrome
(ACS) [12]. CT of the abdomen and pelvis showed a
large retroperitoneal hematoma (Figure 1). The patient
was initially treated with transfusion of 8 units of packed
red cells (PRC) and 4 units of fresh frozen plasma (FFP).
Despite adequate fluid and blood product resuscitation
the patient remained unstable so that the large retroperi-
toneal hematoma had to be surgically removed on the 8
th
ICU-day. The patient remained in the ICU for 47 days.
2
nd Case presentation
A 59-year-old White-Asian male was admitted to hos-
pital and required support with Heart Mate II Thora-
tec
(r) LVAS because of terminal heart insufficient due
to idiopathic dilated cardiomyopathy. On the 6
th ICU-
day hemodynamic indicators included elevated heart
rate (HF > 140 b/min), hypotension (Systolic/Diastolic
BP 60/40 mm Hg), elevated Pulmonary Artery Wedge
Pressure (27 mmHg) and Central Venous Pressure
(CVP 16 mmHg) with elevated Systemic - SVR: 1500
dyn × sec/cm
5 and Pulmonary - PVR: 345 dyn × sec/
cm
5 Vascular Resistance made the patient’s mechanical
Figure 2 2
nd case. CT - sagittal plan of a large retroperitoneal hematoma - 17.76 cm.
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sures (Pmax 34 mmHg and high positive expiratory
end-pressure (PEEP > 10) in order to maintain ade-
quate oxygenation. During the next hours the patient
became anuric with IAP of 22 mmHg. CT revealed a
17,76 cm (Figure 2, 3) retroperitoneal hematoma that
was surgically removed. The retroperitoneum had to
be packed and a re-exploration was necessary 72 h
later before the final closure. The patient was dis-
charged from the ICU on 56




A 64-year-old Caucasian female on 10
th postoperative
day after Heart Mate II Thoratec
(r) LVAS became anu-
ric while IAP was 23 mmHg. CT revealed a 30 cm ret-
roperitoneal hematoma that was surgically removed
(Figure 4, 5, 6). The patient died on the 89
th postopera-




A 61-year-old Caucasian female required mechanical
ventilation and dialysis due to respiratory distress syn-
drome and anuria on 13
th postoperative day after Heart
Mate II Thoratec
(r) LVAS. CT on 15
th postoperative day
revealed a large retroperitoneal hematoma that was sur-
gically removed (Figure 7). The patient remained in the
ICU for 63 days.
Discussion
Postoperative hemorrhage is common among patients
with VADs and many of them have risk factors predis-
posing to hemorrhage. Risk factors for significant
hemorrhage include coagulopathy due to hepatic con-
gestion associated with severe heart failure, compro-
mised nutritional status, preoperative anticoagulation
therapies, and previous cardiac surgery [13]. Although
extensive bleeding usually occurs into the mediastinum
or pericardial space, VADs can have other complications
n o tc o n f i n e dt ot h ec h e s t .H e m o l y s i sa n dr e s u l t i n g
Figure 3 2
nd case. CT - axial plan of the hematoma shifting the right ureter to the middle line.
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John R. [14] and Kamdar F. [15] axial flow devices
(Heart Mate II to our cases) seem to be associated with
higher rate of gastrointestinal bleeding, ventricular
arrhythmias and intracranial hemorrhage.
All of our patients developed IAH as a consequence of
large retroperitoneal hematoma and reduced intra-
abdominal volume. This was inferred by changes in the
patient’s hepatic transaminases and was manifested by
oliguria, raised abdominal pressure and inadequate oxy-
genation result in hypercapnia and acidosis requiring
high PEEP and peak ventilator pressures, which exacer-
bate the hemodynamic abnormalities.
Retroperitoneal hematoma among patients in the ICU
is a well-recognized but relative rare condition with an
incidence of 0.1%, although has been reported at 0.6 -
6.6% of patients undergoing therapeutic anticoagulation
[16,17]. Warfarin, unfractioned and low-molecular
heparin have all been implicated [18,9].
All the patients in our cases before operation and in
order to receive a LAD or a Bi-VAD they were
examined for Heparin Induced Thrombocytopenia
(ELISA & HIPAA). In all cases the HIT test was nega-
tive. After the implantation of the assist device the num-
ber of platelets was reduced but the post- operation
labor examination didn’t provide any signs of HIT.
Appendix 1 demonstrates the 4 Grades of IAH
according to the World Society of the Abdominal Com-
partment Syndrome. The mortality rate in patients with
IAH and ACS varies from 29 to 62% and is usually due
to multiple organ failure and sepsis [19-21]. A diverse
range of associated conditions may lead to from
IAH to ACS requiring aggressive fluid resuscitation
(Appendix 2).
The earliest manifestation of ACS is reported by
Eddy et al. [22] to be the pulmonary dysfunction. IAP
is transmitted to the thorax both directly and through
cephalad deviation of the diaphragm. This significantly
increases intrathoracic pressure resulting in extrinsic
compression of the pulmonary parenchyma and devel-
opment of pulmonary dysfunction [23,24]. Increased
intrapleural pressures resulting from transmitted
Figure 4 3
rd case. CT - sagittal plan demonstrating a 30 cm hematoma.
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hemodynamic parameters including CVP and PAWP
resulting in false LVAD or PVAD settings. In our ser-
ies of cases we noted that accurate prediction of end-
diastolic filling pressures was no longer reliable to be
made from PAWP equations but via transoesophageal
echocardiography. Significant hemodynamic changes
have been demonstrated with IAP above 20 mmHg
[25].
Oliguria or even anuria develops despite measured
normal or mildly elevated CPV and PAWP due to IAH-
induced reductions in renal blood flow and function
[26,27]. Because of IAP renal vein and renal vascular
resistance are both significant elevated leading to
impaired glomerular and tubular renal function and
reduction in urinary output [23,26,27]. Nevertheless
interesting is the fact that renal failure in the absence of
p u l m o n a r yd y s f u n c t i o ni sn o tl i k e l yt ob et h er e s u l to f
IAH [22].
Because many of the effects of ACS are clinically
indistinguishable from those of other common entities
related to critically ill patients, it is probable that the
influence of an elevated IAP is not infrequently missed
in a patient with multifactorial complications. As a
result, clinicians must possess a high index of suspicion
and monitor IAP frequently. Contemporary measure-
ment of the IAP outside of the laboratory is accom-
plished by a variety of means. These include direct
measurement of IAP by means of an intra-peritoneal
catheter, as is done during laparoscopy. Bedside mea-
surement of IAP has been accomplished by transduction
of pressures from indwelling femoral vein, rectal, gastric
and urinary bladder catheters. The latter method is used
in our institution and is possible by measuring intra-
cystic pressure (ICP) as a reflection of IAP using a Foley
catheter [28-30] although large series of human studies
correlating ICP and IAP are lacking to date [31]. Con-
tinuous Intra-cystic pressure measure was used to deter-
mine the IAP indirectly at the era of the first signs of
IAH.
Chest radiography can be used to evaluate gross posi-
tioning of the pump and the inflow and outflow
Figure 5 3
rd case. CT - axial plan of a huge hematoma shifting the whole right renal to the middle line.
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loss of lung volume but these findings seem to be diffi-
cult to identify in patients with VADs. These changes
have been demonstrated with IAP above 15 mmHg [25].
Transoesophageal echocardiography was routinely
employed to all of our patients during the intraoperative
and perioperative periods to evaluate thrombus forma-
tion, pump flow, mechanical complications and ventri-
cular filling and uploading but CT detected in all cases
the problem. Common CT features included extrinsic
compression of the inferior vena cava (IVC), positive
round belly sign and an anteroposterior-to-transverse
abdominal ratio of more than 80 [32].
The usual treatment of ACS by decompression of the
abdomen, often by laparotomy, in those with moderately
elevated intra-abdominal pressure is growing in vogue
[12,33], although conservative treatment is comprised of
supportive therapy and abdominal decompression with
nasogastric tube and flatus tube.
In our cases the indication of open surgery ACS was
complicated of the presence of the large retroperitoneal
hematoma. We didn’t proceed to a decompressive lapar-
otomy because all of the hematomas were so tense that
the possibility of anterior eruption after abdominal pres-
sure released was high. We preferred to remove the
large hematoma in order to avoid this phenomenon and
in one case we had to pack and re-explore the retroperi-
toneum because of diffuse bleeding.
Before operating hematological values were restored
and coagulopathy cascade was corrected by replacement
of coagulation factors. In all patients from the second
postoperative day (after LVAD or PVAD implantation)
and till weaning from mechanical ventilation (MV)
unfractioned heparin was used in continuous 24 h
pump perfusion without discharge aiming a target aPTT
50-60 sec. After weaning from MV and two days after
the last drainage was removed all of the patients
received additional anticoagulation therapy, initially
phenprocoumon 3 mg (Marcumar
(r)) aiming a target




(r) were not discontinued
after hospital discharge.
Figure 6 3
rd case. CT - axial plan of the hematoma.
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acid and metabolites from reperfused tissues after the
abdomen decompression [34,35]. we used in all cases a
two liter solution consisting of 0.45% Normal Saline with
50 gr of Mannitol and 50 mEq of Sodium Bicarbonate [36].
Conclusion
IAH has a significant role in contributing to the early
multiple organ dysfunction syndrome (MODS). The pre-
sentation is varied and may be vague and diagnosis is
often delayed. The patients who have retroperitoneal
hematoma as cause of the IAH often do not have any
obvious clinical signs. Relative hypotension and mild
tachycardia are most of the time present. Any abnormal
and sudden increase in the volume of any component of
the intra-peritoneal or extra-peritoneal spaces can cause
Intra-abdominal Hypertension. When associated with
organ dysfunction (elevated airway pressure, cardiac out-
put reduction and oliguria) it meets the criteria for
Abdomen Compartment Syndrome. Treatment consists
of prompt surgical decompression, volemic resuscitation
and any further strategy is based on recognition of
resultant organ dysfunction.
Our report finally indicates that ACS can occur out-
side the typical setting of abdominal surgery or trauma,
decompressive laparotomy is not always the gold stan-
d a r da n dp a t i e n t sw i t hV A D sm a yb ea th i g hr i s kf o r
postoperative IAH and ACS.
Consent
Written informed consent was obtained from our
patients for publication of this case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
Appendices
Appendix 1
IAH Grading Systemaccording to the WSACS
Grade I: IAP 12-15 mmHg
Grade II: IAP 16-20 mmHg
Grade III: IAP 21-25 mmHg
Grade IV: IAP > 25 mmHg
Figure 7 4
th case. CT - axial plan of the hematoma.
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Risk factors responsible for IAH/ACSaccording to the
WSACS
Mechanical ventilation
Acidosis (pH < 7,2)
Polytransfusion (>10U Packed Red Blood/24 h)






Abdominal surgery, especially with fascial closures
Massive fluid resuscitation (>5 lt colloid or crystalloid/
24 h)




Massive incisional hernia repair
Damage control laparotomy
Laparoscopy with excessive inflation pressures
High Body Mass Index (>30 Kg/m
2)
Coagulopathy




Intra-abdominal or retroperitoneal tumors
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